Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2023-10-30
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need.
Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brief Hypnosis Intervention for Palliative Care Patients and Their Relatives.
NCT05300126
Hypnosis and Meditation for Cancer Pain
NCT03558594
Cognitive Trance, Hypnosis and Meditation in Oncology
NCT04873661
Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners
NCT03144154
Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients
NCT05943301
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anxiety scores
anxiety questionnaire
Patient undergoing hypnosis session will have their anxiety measured just before the third session of hypnosis and after during a telephonic consultation. The result will be compared to the anxiety level before the first hypnosis session
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
anxiety questionnaire
Patient undergoing hypnosis session will have their anxiety measured just before the third session of hypnosis and after during a telephonic consultation. The result will be compared to the anxiety level before the first hypnosis session
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients starting hypnotherapy for anxiety disorders.
* Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21
* Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease.
* Diagnosis announcement less than 2 months old
Exclusion Criteria
* Adults subject to a legal protection measure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas BERT
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service MB1 - Hôpital Lyon Sud - HCL
Lyon, Pierre-Bénite, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL23_0336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.